[1]
Lalani, A.-K.A. , Kapoor, A., Basappa, N.S. , Bhindi, B. , Bjarnason, G.A. , Bosse, D. , Breau, R.H. , Canil, C.M. , Cardenas, L.M. , Castonguay, V. , Chavez-Munoz, C. , Chu, W., Dudani, S. , Graham, J. , Heng, D.Y. , Kollmannsberger, C. , Lattouf, J.-B. , Morgan, S. , Reaume, M.N., Richard, P.O. , Swaminath, A. , Tanguay, S. , Wood, L.A. and Lavallée, L.T. 2023. Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement . Canadian Urological Association Journal. 17, 5 (Apr. 2023), E154–63. DOI:https://doi.org/10.5489/cuaj.8381.